Transrectal Doppler ultrasound during prostate biopsy: Clinical utility and limitations - Abstract

OBJECTIVE: To determine the clinical utility and limitations of guided prostate biopsy Power Doppler in patients with elevated serum PSA levels.

MATERIALS AND METHOD: Prospective study. From April 2012 to May 2013, 111 men over 45 years of age with serum PSA level greater than 4.0ng/dl who underwent a transrectal prostate biopsy were included. The hypoechoic nodules in the peripheral region were considered positive on the gray scale. Subsequently, the study was conducted with the Power Doppler, where the vascularization of suspicious images was analyzed for sampling. In addition, samples were taken from the suspected areas when performing the digital rectal examination. We calculated sensitivity, specificity, positive predictive value and negative predictive value of the three tests (digital rectal examination, standard gray scale ultrasound and power Doppler).

RESULTS: Prostate cancer was diagnosed in 48 of the 111 patients (43%). Fifty-nine cases (53%) were defined as positive with the Power Doppler. Of these, 39 (66%) corresponded to a diagnosis of prostate adenocarcinoma. The Power Doppler was positive in 39 cases of the 48 patients diagnosed with cancer and the gray scale ultrasound was positive in 31 cases. Overall sensitivity of the power Doppler was 81%, specificity 68%, PPV 66% and NPV 82%, which was higher compared to the other methods (P< .05).

CONCLUSION: Currently, prostate biopsy using Power Doppler does not seem to identify prostate cancer with sufficient accuracy to omit the guided systematic biopsy gray scale, the combined use of these methods being preferable.

Written by:
Ezquer A, Ortega Hrescak MC, Sanagua C, Roggia-Rebullida P, López R, Cenice F, Veglia FH, Veglia F, Fernández A.   Are you the author?
Instituto Urológico Privado Prof. Dr. Ronald Parada Parejas, San Miguel de Tucumán, Tucumán, Argentina.  

Reference: Actas Urol Esp. 2014 Mar 13. pii: S0210-4806(14)00046-1.
doi: 10.1016/j.acuro.2014.02.009


PubMed Abstract
PMID: 24630842

Article in English, Spanish.

UroToday.com Prostate Cancer Section